Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. (Q51984235)
Jump to navigation
Jump to search
scientific article published in May 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. |
scientific article published in May 1999 |
Statements
1 reference
Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. (English)
1 reference
Revicki DA
1 reference
Moyle G
1 reference
Stellbrink HJ
1 reference
Barker C
1 reference
1 May 1999
1 reference
1 reference
13
1 reference
7
1 reference
851-858
1 reference
Identifiers
1 reference